Scailyte Closes Series A Funding With a CHF 6 Million Investment to Develop Strategic Partnerships i
Scailyte closes Series A funding with a CHF 6 million investment to develop strategic partnerships Scailyte closes Series A funding with a CHF 6 million investment to develop strategic partnerships in immuno-oncology BASEL, Switzerland - September 21, 2022...
United States Gianpaolo Chiriano Peter Ibbotson Juana Lucia Flores Candia Nilogen Oncosystems Kaloyan Gospodinov
Source: pharmiweb.com